共 78 条
[11]
Keystone EC(2012)Rituximab is more effective than second anti-TNF therapy in rheumatoid arthritis patients and previous TNFalpha blocker failure Biologics. 6 191-199
[12]
Kavanaugh AF(2015)The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor Ann Rheum Dis 74 430-436
[13]
Sharp JT(2016)Non-TNF-targeted biologic vs. a second anti-TNF drug to treat rheumatoid arthritis in patients with insufficient response to a first anti-TNF drug: a randomized clinical trial JAMA 316 1172-1180
[14]
Klareskog L(2013)Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritis Ann Rheum Dis 72 1897-1904
[15]
van der Heijde D(2014)Biological agents in monotherapy for the treatment of rheumatoid arthritis Swiss Med Wkly. 144 w13950-S177
[16]
de Jager JP(2005)The CORRONA database Clin Exp Rheumatol 23 S172-99
[17]
Lipsky PE(2016)The Corrona US registry of rheumatic and autoimmune diseases Clin Exp Rheumatol 34 96-1798
[18]
van der Heijde DM(2014)Linkage of a de-identified United States rheumatoid arthritis registry with administrative data to facilitate comparative effectiveness research Arthritis Care Res (Hoboken). 66 1790-424
[19]
St Clair EW(2011)An introduction to propensity score methods for reducing the effects of confounding in observational studies Multivariate Behav Res. 46 399-55
[20]
Maini R(1983)The central role of propensity score in observational studies for causal effects Biometrika 70 41-1652